Problems associated with clinical trials of ayurvedic medicines;Problemas associados com ensaios clínicos de medicamentos Ayurvédicos

Revista Brasileira de Farmacognosia

Volumn 20, Issue 2, 2010, Pages 276-281

  Sharma, Ashish K ^a   Kumar, Rajesh ^b   Mishra, Anurag ^c   Gupta, Rajiv ^c  

^a Adarsh Vijendra Institute of Pharmaceutical Sciences   (India)

^b Faculty of Pharmacy   (India)

^c BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

Author keywords

Clinical trials; Good manufacturing practice; Placebo; World health organization

Indexed keywords

AYURVEDIC DRUG; CASCARA SAGRADA; CHAMOMILE; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; SILYBUM MARIANUM EXTRACT; TANACETUM PARTHENIUM EXTRACT;

ARTICLE; AYURVEDA; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SCREENING; GINKGO BILOBA; HERBAL MEDICINE; HUMAN; NONHUMAN; PRACTICE GUIDELINE; QUALITY CONTROL; STANDARDIZATION; WORLD HEALTH ORGANIZATION;

EID: 77954753834     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2010000200023     Document Type: Article

References (34)

1. Armstrong NC, Ernst E 1999. The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials. Brit J Clin Pharmacol 48: 262-264.
2. Bauer R, Tittel G 1996. Quality assessment of herbal preparations as a precondition of pharmacological and clinical studies. Phytomedicine 2: 193-198.
3. Bhattaram VA, Graefe U, Kohlert C, Veit M, Derendorf H 2002. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine 3: 1-33.
4. Brevoort P 1995. The U.S. botanical market: An overview. Herbal Gram 36: 49-59.
5. Calixto JB 2000. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res 33: 179-189.
6. Chaudhary Roy, Chandrashekharan M, Mishra S 2001. Embryotoxicity and teratogenicity studies of an ayurvedic contraceptives-pippalyadi vati. J Ethnopharmacol 74:189-193.
7. Chan K 2003. Some aspects of toxic contaminants in herbal medicines. Chemosphere 52: 1361-1371
8. Dahanukar SA, Thatte UM 1997. Current status of ayurveda in phytomedicine. Phytomedicine 4: 359-368.
9. Drews J 1995. Intent and coincidence in pharmaceutical discovery. The impact of biotechnology. Arzneimittel- Forschung 45: 934-939
10. Eisenburg DM, Davis RB, Ettner SL, Appeal S, Wilkey S, Van Rompay M, Kessler RC 1998. Trends in alternative medicine use in the United States, 1990-1997, Results of a follow-up national survey. JAMA-J Am Med Assoc 280: 1569-1575.
11. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR & Delbanco TL 1993. Unconventional medicine in the United States. New Engl J Med 328: 246-252.
12. Ernst E, Rand JI, Stevinson C 1998. Complementary therapies for depression - An overview. Arch Gen Psychiat 55: 1026-1032.
13. Fisher P, Ward A 1994. Complementary medicine in Europe. Brit Med J 309: 107-111.
14. Fugh-Berman A 2000. Herb-drug interactions. Lancet 355:134-138.
15. Grunwald J 1995. The European phytomedicines market: figures, trends, analysis. Herbal Gram 34: 60-65.
16. Harrer G, Schimidt U, Kuhn U, Biller A 1999. Comparison of equivalent between the St. John's wort extract LoHyp-57 and fluoxetine. Arzneimittel-Forschung 49: 289-296.
17. Kristofferson S 1996. Uptake of alternative medicine in Australia. Lancet 347: 569-573
18. Linde K, Jonas WB, Melchart D, Willich S 2001. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol 30: 526-531.
19. Marcus D, Grollman A 2002. Botanical medicines - The need for new regulations. New Engl J Med 347: 2073-2076.
20. MacLennan AH, Wilson DH, Taylor AW 1996. Prevalence and cost of alternative medicine in Australia. Lancet 347: 569-573.
21. Moore C, Adler R 2000. Herbal vitamins: lead toxicity and developmental delay. Am Acad Pediatrics 106: 600-602.
22. Pittler MH, Abbot NC, Harkness EF, Ernst E 2000. Location bias in controlled clinical trials of complementary/alternative therapies. Int J Epidemiol 53: 485-489.
23. Robbers JE, Tyler VE 1999. Tyler's Herbs of Choice: The Therapeutic Use of Phytomedicinals. The Haworth Herbal Press, Inc., New York. pp 124-158.
24. Rothman KJ, Michels KB 1994. The continuing unethical use of placebo controls. N Engl J Med 331: 394-398.
25. Robert BS, Stefanos K, Janet P, Michael JB, David ME, Roger BD, Russell SP 2004. Heavy Metal Content of Ayurvedic Herbal Medicine Products. JAMA 292:2868-73
26. Shiapush M 1998. Postmodern values, dissatisfaction with conventional medicine and popularity of alternative therapies. J Sociol 34: 58-70
27. Srinivasan K 2005. Spices as influencers of body metabolism: an overview of three decades of research. Food Res Int 38: 77-86.
28. Shukla NK, Narang R, Nair NGK, Radhakrishna S, Satyavati G 1991. Multicentric randomized controlled clinical trial of Kshaarasootra (Ayurvedic medicated thread) in the management of fistula-in-ano. Indian J Med Res 94: 177-185.
29. Straus S 2002. Herbal medicines - What's in the bottle? New Engl J Med 347: 1997-1998.
30. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE 2006. Health benefits of herbs and spices: the past, the present, the future. Med J Aust 185 (4 Suppl): S4-24.
31. Thatte UM, Rege NN, Phatak S, Dahanukar SA 1993. The flip side of Ayurveda. J Postgrad Med 39: 179-182.
32. Thatte UM 2005. Clinical resaerch with ayurvedic medicines. Pharma Times 37: 9-10.
33. Vaidya RA, Vaidya ADB, Patwardhan B, Tillu G, Rao Y 2003. Ayurvedic pharmacoepidemiology: a proposed new discipline. J Assoc Physicians India 51:528.
34. Wagner H 1999. Phytomedicine Research in Germany. Environ Health Perspect 107: 779-781.